FDA Adverse Event Malfunction Summary report: N

SYNCHRON® LX®I 725 CLINICAL SYSTEM

MDR report key: 1580104 · Received January 19, 2010

Report

Report Number
2050012-2010-00007
Event Type
Malfunction
Date Received
January 19, 2010
Date of Event
December 14, 2009
Report Date
January 19, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
CHH
PMA / PMN Number
K023049
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

QC WAS WITHIN CUSTOMER SPECIFICATIONS BEFORE THE EVENT. A FIELD SERVICE ENGINEER (FSE) WAS ON-SITE AND REPAIRED, REPLACED OR ALIGNED THE SAMPLE AND REAGENT SYRINGE SYSTEM COMPONENTS, THE SAMPLE AND REAGENT PROBE SYSTEM COMPONENTS, AND THE SAMPLE AND REAGENT MIXER SYSTEM COMPONENTS. DUE TO A POTENTIAL FOR THIS EVENT TO RECUR UNKNOWINGLY, THERE IS POTENTIAL THAT A PIVOTAL ASSAY COULD BE ERRONEOUSLY REPORTED AND TREATMENT DECISION MAY BE AFFECTED. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING MULTIPLE FALSELY HIGH CHOLESTEROL, TRIGLYCERIDE AND HDL-CHOLESTEROL RESULTS GENERATED BY THE SYNCHRON LXI 725 CLINICAL SYSTEM. THE INITIAL CHOLESTEROL, TRIGLYCERIDE AND HDL RESULTS WERE IN THE RANGE 230-452, 108-1046 AND 39-111 UNITS RESPECTIVELY; AND THE REPEAT RESULTS WERE IN THE RANGE 150-299, 66-615 AND 30-72 UNITS RESPECTIVELY. THE ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE LABORATORY BELIEVES THAT ONE OR TWO PATIENTS WERE PRESCRIBED MEDICATION BASED ON THE ERRONEOUS RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYNCHRON® LX®I 725 CLINICAL SYSTEM CLINICAL CHEMISTRY ANALYZER CHH BECKMAN COULTER INC. LX®I 725 NA

Patients

Seq Age Sex Outcome Treatment
1